Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02224391
Other study ID # 2013-0999
Secondary ID NCI-2015-0060920
Status Completed
Phase N/A
First received
Last updated
Start date January 20, 2016
Est. completion date March 15, 2021

Study information

Verified date March 2023
Source M.D. Anderson Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized clinical trial studies how well a smartphone-delivered attentional bias modification training works in helping patients quit smoking. Smartphone-delivered attentional bias modification training may help patients quit smoking by reducing the attentional bias (the tendency of one's perception to be affected by their recurring thoughts) towards smoking cues that developed over time as a result of conditioning processes through which smoking cues become important.


Description:

PRIMARY OBJECTIVES: I. To determine the feasibility of smartphone-delivered, in-home attentional bias modification (ABM) to reduce attentional bias (AB) to smoking cues and to reduce smoking behavior in the short- and long-term. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive ABM training over 30 minutes through a smartphone on days 1-14. Patients then receive nicotine patches for up to 8 weeks. ARM II: Patients undergo sham training on days 1-14. Patients then receive nicotine patches for up to 8 weeks. After completion of study treatment, patients are followed up on days 15, 29, 43, 57, and 72.


Recruitment information / eligibility

Status Completed
Enrollment 311
Est. completion date March 15, 2021
Est. primary completion date March 15, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Smoke an average of 5 or more cigarettes or little cigars per day (CPD) prior to telephone screen - Produce an expired carbon monoxide (CO) level greater than or equal to 6 parts per million (ppm) or a NicAlert reading of > 2 - Have a working telephone - Interested in quitting smoking in the next 30 days - Fluency in spoken and written English - Must sign the picture consent form Exclusion Criteria: - Taking psychotropic, anticonvulsive, or narcotic medication - Meet criteria for a current major depressive episode or suicidality - Have a history of neurological illness or closed head injury - Report uncorrected vision problems - Involved in current smoking cessation activity - Testing positive on a urine drug screen for drugs of abuse/potential abuse - Women who are pregnant or breastfeeding - Considered by the investigator to be an unsuitable or unstable candidate (e.g., due to cognitive impairment) - Shares the same address as a currently enrolled participant - Unwilling to alter or remove hairstyle, hair extensions, or wig during the clinic visits to allow for correct electroencephalography (EEG) sensor placement - Reports diagnosis of seizure disorder - Unwilling to use nicotine replacement therapy (NRT) patches

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Computer-Assisted Smoking Cessation Intervention
Receive ABM training via a smartphone
Other:
Laboratory Biomarker Analysis
Correlative studies
Drug:
Nicotine Patch
Given via transdermal patch
Other:
Questionnaire Administration
Ancillary studies
Sham Intervention
Undergo sham training

Locations

Country Name City State
United States M D Anderson Cancer Center Houston Texas

Sponsors (2)

Lead Sponsor Collaborator
M.D. Anderson Cancer Center National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Modified Dot-probe Task Modified dot-probe task evaluated by using 2 (group: ABM vs. sham) X 3 (session: baseline, 1-day post-training, and 8-weeks post-training) linear mixed model using RT difference scores (neutral-cigarette) as the dependent measures and subject as the random effect. Up to 8 weeks post-training
Primary Smoking Stroop Task The Stroop task will consist of three blocks, with a 5-s rest period between blocks: (a) practice (40 trials), (b) neutral words (80 trials), and (c) smoking words (80 trials). The score will be calculated by taking the mean RT difference between the smoking and neutral words on trials with correct responses within the response window. Up to 8 weeks post-training
Secondary Cigarette Per Day (CPD) Mean number of cigarettes per day smoked for the seven days preceding each time point. Up to 8 weeks post-training
Secondary Expired Carbon Monoxide (CO) Mean expired carbon monoxide, in ppm (parts per million), at each time point. Up to 8 weeks post-training
Secondary Urinary Cotinine Mean urinary cotinine, measured in ng/mL, at each time point. Up to 8 weeks post-training
Secondary Fagerström Test for Nicotine Dependence (FTND) The Fagerström Test for Nicotine Dependence, yes/no items are scored from 0 to 1 and multiple-choice items are scored from 0 to 3. The items are summed to yield a total score of 0-10. The higher the total Fagerström score, the more intense is the patient's physical dependence on nicotine. Mean Fagerström Test for Nicotine Dependence (FTND) questionnaire score at each time point. Up to 8 weeks post-training
Secondary Wisconsin Smoking Withdrawal Scale (WSWS) - Craving Mean Wisconsin Smoking Withdrawal Scale (WSWS) - Craving subscale score at each time point. Participants rate each item on a scale of 0-4 (0=Strongly disagree, 1=Disagree, 2=Feel neutral, 3=Agree, 4=Strongly agree). The subscale to each item is determined on how high they agree on the scale. Mean Wisconsin Smoking Withdrawal Scale (WSWS) - Craving subscale score at each time point. For some items, the subscale is determined on how low they agreed. Each score is determined by the mean of each item that applies. Higher means indicate greater withdrawal. Up to 8 weeks post-training
See also
  Status Clinical Trial Phase
Recruiting NCT03691350 - Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs Early Phase 1
Completed NCT01967082 - APPSPIRE App in Preventing Students From Smoking N/A
Recruiting NCT03865472 - rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers N/A
Withdrawn NCT03668769 - Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking N/A
Completed NCT04060446 - Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation in Current Every Day Cigarette Smokers
Completed NCT00941395 - Enhanced Smoking Cessation for University Students N/A
Completed NCT03669120 - Tailored Smoking Cessation Intervention in Promoting Sexual and Gender Minority Smokers to Quit Smoking N/A
Completed NCT00948129 - Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers N/A
Active, not recruiting NCT03519451 - Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment N/A

External Links